100%
Skip to main content
Platform
GovTribe AI
AI-powered insights to accelerate your government contracting workflow.
MCP Server
Connect GovTribe to your AI tools.
Beacon
Find and connect with key government decision-makers.
Profiles
Federal Agencies
Federal Contract Vehicles
Federal Grant Programs
Major Defense Acquisition Programs
NAICS Categories
PSC Categories
States
Jurisdictions
NIGP Categories
UNSPSC Categories
Vendors
Enrichment By Clearbit
Reports
New Entrants
Funding Analysis
Vehicle Analysis
Groups
Capture
Pipelines
Pursuits
Alerts
Teaming
Data
Awards
Forecasts
Federal Opportunities
State & Local Opportunities
Files
Prime and Subcontractors
Activity
Search
Exports
Solutions
Use Case
Opportunity Identification
Capture Management
Competitive Intelligence
Teaming & Partner Identification
Proposal Management
Strategic Leadership
Go-to-Market Strategy
Industry
Federal Contractors
State & Local Contractors
Grant Seekers
Government Agencies
Research & Consulting
Pricing
More
About Us
Features
Get A Demo
Sign Up
Blog
User Guide
Data Model
GovTribe for Agents
Login
Contact sales
Try for free
Login
Contact sales
Try for free
All Federal Grant Awards
Project Grant R44DA041173
Award Date
4/1/16
Completion Date
8/31/21
Dollars Obligated
$1.4M
Overview
Activity
10
Transactions
10
Subawards
Similar Awards
Federal Agency
National Institute on Drug Abuse
Awardee
SFC Fluidics, Inc. (GTPCCLD8LK26)
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Arkansas, USA
Update #1
Update #2
DEVELOPMENT OF AN IMPLANTABLE ON-DEMAND DRUG DELIVERY DEVICE FOR BEHAVIORAL STUDIES IN SMALL ANIMALS
Posted 8/24/17
5
1
2
Mod #
Description
ReasonForModification
Federal Obligation
Date
Not listed
DEVELOPMENT OF AN IMPLANTABLE ON-DEMAND DRUG DELIVERY DEVICE FOR BEHAVIORAL STUDIES IN SMALL ANIMALS - DEVELOPMENT OF AN IMPLANTABLE ON-DEMAND DRUG DELIVERY DEVICE FOR BEHAVIORAL STUDIES IN SMALL ANIMALS PROJECT SUMMARY: THE SPECIFIC AIMS OF THIS PHASE II PROJECT ARE TO FINALIZE THE DEVELOPMENT OF THE MIN- EPUMPTM, A LOW-COST, BATTERY-OPERATED, WIRELESSLY CONTROLLED, ON-DEMAND OR PROGRAMMABLE DRUG DELIVERY SYSTEM, AND TO ESTABLISH ITS USE IN IMPROVING DRUG ADDICTION AND DRUG DEVELOPMENT MODELS. DURING YEAR 1, THE MIN-EPUMP WILL BE OPTIMIZED FOR RELIABLE IMPLANTATION AND COMFORTABLE WEAR IN ANIMALS AS SMALL AS A RAT. DURING THE SECOND HALF OF PHASE II, THE PUMP WILL BE TESTED EXTENSIVELY TO VALIDATE THIS ENABLING TECHNOLOGY FOR USE IN DRUG ADDICTION RESEARCH, IN PRE-CLINICAL DRUG DEVELOPMENT RESEARCH AND FOR DELIVERY OF THERAPEUTICS IN VETERINARY MEDICINE. THE END OF PHASE II WILL SEE THE DEFINITION OF MANUFACTURING AND OPERATING PARAMETERS FOR MIN- EPUMP AND PUBLICATION OF RESEARCH RESULTS. THE FOLLOWING OBJECTIVES WILL ALLOW FOR COMPLETION OF THE PHASE II PROJECT: OBJECTIVE 1 - MINIATURIZE AND OPTIMIZE MIN-EPUMP FOR EASE-OF-USE AND COMFORT DURING IMPLANTATION IN A RAT MODEL. OBJECTIVE 2 - COMPARE EFFICACY OF MIN-EPUMP TO TRADITIONAL TETHERED-PUMP IN SELF- ADMINISTRATION DRUG ADDICTION RESEARCH AND TEST SOCIAL AND BEHAVIORAL EFFECTS OF AN IMPLANTED PUMP IN A RAT MODEL. OBJECTIVE 3 - SHOW EFFICACY FOR USE OF MIN-EPUMP IN PK/PD RESEARCH USING A DRUG ADDICTION THERAPEUTIC IN A RAT MODEL. OBJECTIVE 4 - SHOW EFFICACY FOR USE OF MIN-EPUMP IN VETERINARY MEDICINE USING A DOG MODEL. OBJECTIVE 5 - FINALIZE THE DESIGN OF THE MIN-EPUMP TO BEST MEET THE NEEDS OF EACH TARGET MARKET SEGMENT AND DEFINE THE MANUFACTURING PROCESS. THIS PROJECT WILL ADDRESS TWO HIGH NEED TECHNOLOGY GAPS IDENTIFIED BY THE NIDA. UNDER THE ORIGINAL PHASE I SOLICITATION, THIS PROJECT DIRECTLY ADDRESSES A SPECIAL NEEDS TOPIC FOR "DEVELOPMENT OF PRE-CLINICAL MODELS FOR ADDICTION." MIN-EPUMP ALSO APPLIES TO THE PROGRAMMATIC PRIORITY RELEASED BY NIDA IN JANUARY OF 2015 FOR PRECLINICAL DRUG DEVELOPMENT ENABLING TECHNOLOGIES.
$88.8k
12/1/22
Not listed
DEVELOPMENT OF AN IMPLANTABLE ON-DEMAND DRUG DELIVERY DEVICE FOR BEHAVIORAL STUDIES IN SMALL ANIMALS - DEVELOPMENT OF AN IMPLANTABLE ON-DEMAND DRUG DELIVERY DEVICE FOR BEHAVIORAL STUDIES IN SMALL ANIMALS PROJECT SUMMARY: THE SPECIFIC AIMS OF THIS PHASE II PROJECT ARE TO FINALIZE THE DEVELOPMENT OF THE MIN- EPUMPTM, A LOW-COST, BATTERY-OPERATED, WIRELESSLY CONTROLLED, ON-DEMAND OR PROGRAMMABLE DRUG DELIVERY SYSTEM, AND TO ESTABLISH ITS USE IN IMPROVING DRUG ADDICTION AND DRUG DEVELOPMENT MODELS. DURING YEAR 1, THE MIN-EPUMP WILL BE OPTIMIZED FOR RELIABLE IMPLANTATION AND COMFORTABLE WEAR IN ANIMALS AS SMALL AS A RAT. DURING THE SECOND HALF OF PHASE II, THE PUMP WILL BE TESTED EXTENSIVELY TO VALIDATE THIS ENABLING TECHNOLOGY FOR USE IN DRUG ADDICTION RESEARCH, IN PRE-CLINICAL DRUG DEVELOPMENT RESEARCH AND FOR DELIVERY OF THERAPEUTICS IN VETERINARY MEDICINE. THE END OF PHASE II WILL SEE THE DEFINITION OF MANUFACTURING AND OPERATING PARAMETERS FOR MIN- EPUMP AND PUBLICATION OF RESEARCH RESULTS. THE FOLLOWING OBJECTIVES WILL ALLOW FOR COMPLETION OF THE PHASE II PROJECT: OBJECTIVE 1 - MINIATURIZE AND OPTIMIZE MIN-EPUMP FOR EASE-OF-USE AND COMFORT DURING IMPLANTATION IN A RAT MODEL. OBJECTIVE 2 - COMPARE EFFICACY OF MIN-EPUMP TO TRADITIONAL TETHERED-PUMP IN SELF- ADMINISTRATION DRUG ADDICTION RESEARCH AND TEST SOCIAL AND BEHAVIORAL EFFECTS OF AN IMPLANTED PUMP IN A RAT MODEL. OBJECTIVE 3 - SHOW EFFICACY FOR USE OF MIN-EPUMP IN PK/PD RESEARCH USING A DRUG ADDICTION THERAPEUTIC IN A RAT MODEL. OBJECTIVE 4 - SHOW EFFICACY FOR USE OF MIN-EPUMP IN VETERINARY MEDICINE USING A DOG MODEL. OBJECTIVE 5 - FINALIZE THE DESIGN OF THE MIN-EPUMP TO BEST MEET THE NEEDS OF EACH TARGET MARKET SEGMENT AND DEFINE THE MANUFACTURING PROCESS. THIS PROJECT WILL ADDRESS TWO HIGH NEED TECHNOLOGY GAPS IDENTIFIED BY THE NIDA. UNDER THE ORIGINAL PHASE I SOLICITATION, THIS PROJECT DIRECTLY ADDRESSES A SPECIAL NEEDS TOPIC FOR "DEVELOPMENT OF PRE-CLINICAL MODELS FOR ADDICTION." MIN-EPUMP ALSO APPLIES TO THE PROGRAMMATIC PRIORITY RELEASED BY NIDA IN JANUARY OF 2015 FOR PRECLINICAL DRUG DEVELOPMENT ENABLING TECHNOLOGIES.
$88.8k
12/1/22
Not listed
DEVELOPMENT OF AN IMPLANTABLE ON-DEMAND DRUG DELIVERY DEVICE FOR BEHAVIORAL STUDIES IN SMALL ANIMALS - DEVELOPMENT OF AN IMPLANTABLE ON-DEMAND DRUG DELIVERY DEVICE FOR BEHAVIORAL STUDIES IN SMALL ANIMALS PROJECT SUMMARY: THE SPECIFIC AIMS OF THIS PHASE II PROJECT ARE TO FINALIZE THE DEVELOPMENT OF THE MIN- EPUMPTM, A LOW-COST, BATTERY-OPERATED, WIRELESSLY CONTROLLED, ON-DEMAND OR PROGRAMMABLE DRUG DELIVERY SYSTEM, AND TO ESTABLISH ITS USE IN IMPROVING DRUG ADDICTION AND DRUG DEVELOPMENT MODELS. DURING YEAR 1, THE MIN-EPUMP WILL BE OPTIMIZED FOR RELIABLE IMPLANTATION AND COMFORTABLE WEAR IN ANIMALS AS SMALL AS A RAT. DURING THE SECOND HALF OF PHASE II, THE PUMP WILL BE TESTED EXTENSIVELY TO VALIDATE THIS ENABLING TECHNOLOGY FOR USE IN DRUG ADDICTION RESEARCH, IN PRE-CLINICAL DRUG DEVELOPMENT RESEARCH AND FOR DELIVERY OF THERAPEUTICS IN VETERINARY MEDICINE. THE END OF PHASE II WILL SEE THE DEFINITION OF MANUFACTURING AND OPERATING PARAMETERS FOR MIN- EPUMP AND PUBLICATION OF RESEARCH RESULTS. THE FOLLOWING OBJECTIVES WILL ALLOW FOR COMPLETION OF THE PHASE II PROJECT: OBJECTIVE 1 - MINIATURIZE AND OPTIMIZE MIN-EPUMP FOR EASE-OF-USE AND COMFORT DURING IMPLANTATION IN A RAT MODEL. OBJECTIVE 2 - COMPARE EFFICACY OF MIN-EPUMP TO TRADITIONAL TETHERED-PUMP IN SELF- ADMINISTRATION DRUG ADDICTION RESEARCH AND TEST SOCIAL AND BEHAVIORAL EFFECTS OF AN IMPLANTED PUMP IN A RAT MODEL. OBJECTIVE 3 - SHOW EFFICACY FOR USE OF MIN-EPUMP IN PK/PD RESEARCH USING A DRUG ADDICTION THERAPEUTIC IN A RAT MODEL. OBJECTIVE 4 - SHOW EFFICACY FOR USE OF MIN-EPUMP IN VETERINARY MEDICINE USING A DOG MODEL. OBJECTIVE 5 - FINALIZE THE DESIGN OF THE MIN-EPUMP TO BEST MEET THE NEEDS OF EACH TARGET MARKET SEGMENT AND DEFINE THE MANUFACTURING PROCESS. THIS PROJECT WILL ADDRESS TWO HIGH NEED TECHNOLOGY GAPS IDENTIFIED BY THE NIDA. UNDER THE ORIGINAL PHASE I SOLICITATION, THIS PROJECT DIRECTLY ADDRESSES A SPECIAL NEEDS TOPIC FOR "DEVELOPMENT OF PRE-CLINICAL MODELS FOR ADDICTION." MIN-EPUMP ALSO APPLIES TO THE PROGRAMMATIC PRIORITY RELEASED BY NIDA IN JANUARY OF 2015 FOR PRECLINICAL DRUG DEVELOPMENT ENABLING TECHNOLOGIES.
($89k)
2/16/22
Not listed
DEVELOPMENT OF AN IMPLANTABLE ON-DEMAND DRUG DELIVERY DEVICE FOR BEHAVIORAL STUDIES IN SMALL ANIMALS - DEVELOPMENT OF AN IMPLANTABLE ON-DEMAND DRUG DELIVERY DEVICE FOR BEHAVIORAL STUDIES IN SMALL ANIMALS PROJECT SUMMARY: THE SPECIFIC AIMS OF THIS PHASE II PROJECT ARE TO FINALIZE THE DEVELOPMENT OF THE MIN- EPUMPTM, A LOW-COST, BATTERY-OPERATED, WIRELESSLY CONTROLLED, ON-DEMAND OR PROGRAMMABLE DRUG DELIVERY SYSTEM, AND TO ESTABLISH ITS USE IN IMPROVING DRUG ADDICTION AND DRUG DEVELOPMENT MODELS. DURING YEAR 1, THE MIN-EPUMP WILL BE OPTIMIZED FOR RELIABLE IMPLANTATION AND COMFORTABLE WEAR IN ANIMALS AS SMALL AS A RAT. DURING THE SECOND HALF OF PHASE II, THE PUMP WILL BE TESTED EXTENSIVELY TO VALIDATE THIS ENABLING TECHNOLOGY FOR USE IN DRUG ADDICTION RESEARCH, IN PRE-CLINICAL DRUG DEVELOPMENT RESEARCH AND FOR DELIVERY OF THERAPEUTICS IN VETERINARY MEDICINE. THE END OF PHASE II WILL SEE THE DEFINITION OF MANUFACTURING AND OPERATING PARAMETERS FOR MIN- EPUMP AND PUBLICATION OF RESEARCH RESULTS. THE FOLLOWING OBJECTIVES WILL ALLOW FOR COMPLETION OF THE PHASE II PROJECT: OBJECTIVE 1 - MINIATURIZE AND OPTIMIZE MIN-EPUMP FOR EASE-OF-USE AND COMFORT DURING IMPLANTATION IN A RAT MODEL. OBJECTIVE 2 - COMPARE EFFICACY OF MIN-EPUMP TO TRADITIONAL TETHERED-PUMP IN SELF- ADMINISTRATION DRUG ADDICTION RESEARCH AND TEST SOCIAL AND BEHAVIORAL EFFECTS OF AN IMPLANTED PUMP IN A RAT MODEL. OBJECTIVE 3 - SHOW EFFICACY FOR USE OF MIN-EPUMP IN PK/PD RESEARCH USING A DRUG ADDICTION THERAPEUTIC IN A RAT MODEL. OBJECTIVE 4 - SHOW EFFICACY FOR USE OF MIN-EPUMP IN VETERINARY MEDICINE USING A DOG MODEL. OBJECTIVE 5 - FINALIZE THE DESIGN OF THE MIN-EPUMP TO BEST MEET THE NEEDS OF EACH TARGET MARKET SEGMENT AND DEFINE THE MANUFACTURING PROCESS. THIS PROJECT WILL ADDRESS TWO HIGH NEED TECHNOLOGY GAPS IDENTIFIED BY THE NIDA. UNDER THE ORIGINAL PHASE I SOLICITATION, THIS PROJECT DIRECTLY ADDRESSES A SPECIAL NEEDS TOPIC FOR "DEVELOPMENT OF PRE-CLINICAL MODELS FOR ADDICTION." MIN-EPUMP ALSO APPLIES TO THE PROGRAMMATIC PRIORITY RELEASED BY NIDA IN JANUARY OF 2015 FOR PRECLINICAL DRUG DEVELOPMENT ENABLING TECHNOLOGIES.
($89k)
2/16/22
Not listed
DEVELOPMENT OF AN IMPLANTABLE ON-DEMAND DRUG DELIVERY DEVICE FOR BEHAVIORAL STUDIES IN SMALL ANIMALS - DEVELOPMENT OF AN IMPLANTABLE ON-DEMAND DRUG DELIVERY DEVICE FOR BEHAVIORAL STUDIES IN SMALL ANIMALS PROJECT SUMMARY: THE SPECIFIC AIMS OF THIS PHASE II PROJECT ARE TO FINALIZE THE DEVELOPMENT OF THE MIN- EPUMPTM, A LOW-COST, BATTERY-OPERATED, WIRELESSLY CONTROLLED, ON-DEMAND OR PROGRAMMABLE DRUG DELIVERY SYSTEM, AND TO ESTABLISH ITS USE IN IMPROVING DRUG ADDICTION AND DRUG DEVELOPMENT MODELS. DURING YEAR 1, THE MIN-EPUMP WILL BE OPTIMIZED FOR RELIABLE IMPLANTATION AND COMFORTABLE WEAR IN ANIMALS AS SMALL AS A RAT. DURING THE SECOND HALF OF PHASE II, THE PUMP WILL BE TESTED EXTENSIVELY TO VALIDATE THIS ENABLING TECHNOLOGY FOR USE IN DRUG ADDICTION RESEARCH, IN PRE-CLINICAL DRUG DEVELOPMENT RESEARCH AND FOR DELIVERY OF THERAPEUTICS IN VETERINARY MEDICINE. THE END OF PHASE II WILL SEE THE DEFINITION OF MANUFACTURING AND OPERATING PARAMETERS FOR MIN- EPUMP AND PUBLICATION OF RESEARCH RESULTS. THE FOLLOWING OBJECTIVES WILL ALLOW FOR COMPLETION OF THE PHASE II PROJECT: OBJECTIVE 1 - MINIATURIZE AND OPTIMIZE MIN-EPUMP FOR EASE-OF-USE AND COMFORT DURING IMPLANTATION IN A RAT MODEL. OBJECTIVE 2 - COMPARE EFFICACY OF MIN-EPUMP TO TRADITIONAL TETHERED-PUMP IN SELF- ADMINISTRATION DRUG ADDICTION RESEARCH AND TEST SOCIAL AND BEHAVIORAL EFFECTS OF AN IMPLANTED PUMP IN A RAT MODEL. OBJECTIVE 3 - SHOW EFFICACY FOR USE OF MIN-EPUMP IN PK/PD RESEARCH USING A DRUG ADDICTION THERAPEUTIC IN A RAT MODEL. OBJECTIVE 4 - SHOW EFFICACY FOR USE OF MIN-EPUMP IN VETERINARY MEDICINE USING A DOG MODEL. OBJECTIVE 5 - FINALIZE THE DESIGN OF THE MIN-EPUMP TO BEST MEET THE NEEDS OF EACH TARGET MARKET SEGMENT AND DEFINE THE MANUFACTURING PROCESS. THIS PROJECT WILL ADDRESS TWO HIGH NEED TECHNOLOGY GAPS IDENTIFIED BY THE NIDA. UNDER THE ORIGINAL PHASE I SOLICITATION, THIS PROJECT DIRECTLY ADDRESSES A SPECIAL NEEDS TOPIC FOR "DEVELOPMENT OF PRE-CLINICAL MODELS FOR ADDICTION." MIN-EPUMP ALSO APPLIES TO THE PROGRAMMATIC PRIORITY RELEASED BY NIDA IN JANUARY OF 2015 FOR PRECLINICAL DRUG DEVELOPMENT ENABLING TECHNOLOGIES.
($89k)
2/16/22